Teva Pharmaceutical Industries LimitedTEVA

Where TEVA's Payout Ratio sits inside its own 10-year distribution, with the yearly high, low and average.

$36.85+0.09 (+0.24%)Previous close
NYSEHealthcare

TEVA Payout Ratio: current value, 10-year range and year-by-year history

Payout Ratio History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
No data available

TEVA Payout Ratio by year

Yearly range of TEVA’s payout ratio from 2016 to 2018. Over the full period it ranged from 3.4% to 43.9%, averaging 26.8%.

TEVA Payout Ratio — yearly low, average, high and year-end values
YearLowAverageHighYear-end
20183.4%7.6%14.1%3.4%
201732.8%39.4%43.9%32.8%
201629.1%30.5%31.9%31.9%

Get notified when TEVA Payout Ratio crosses a threshold

Free — one alert setup, notifications by push, Telegram, or Discord.

What fraction of free cash flow is paid out as dividends. More reliable than the earnings-based payout ratio because cash is harder to manipulate through accounting choices. Low ratio = room to grow the dividend and absorb an earnings dip. High ratio = dividend is consuming most of the cash generated.

FormulaTTM Dividends Per Share / (TTM FCF ÷ Shares) × 100%
Full guide
How to read this chart

A steadily rising FCF payout ratio warrants scrutiny only if FCF itself is flat or falling — that means the company is paying out a larger slice of shrinking cash. A high but stable ratio in a capital-light business (e.g. consumer staples) can be perfectly sustainable.

Key caveats
  • FCF can be lumpy: large one-off capex or working-capital swings distort a single year. Look at the multi-year trend rather than any single data point.
  • Utilities and REITs naturally sustain 60–90% FCF payout ratios; industrials and tech companies typically run 20–50%. Always compare to sector context.
Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.